Recent Updates
Recently added Catalysts

Chlorhexidine Gluconate

Phase 3

Surgery | Small molecule | Other |Medline Inc.|Last Updated: May 21, 2021

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedPLACEBO_CONTROLLED
Total Trials3
Total Enrollment1,566
FDA Designations
No designations recorded
Clinical Trials (3)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT02526667Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy VolunteersPHASE3 COMPLETED 340Aug 1, 2015Dec 1, 2015Sep 28, 20201 Romania
NCT02291601Preoperative CHG Cloth on Healthy SubjectsPHASE3 COMPLETED 879Oct 1, 2014Sep 1, 2015Apr 30, 20211 United States
NCT02222896Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy SubjectsPHASE3 COMPLETED 347Aug 1, 2014May 1, 2015May 21, 20211 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Responder Rates (%) of Sites Identified for Bacterial Reduction on the Abdomen and Groin
10 minutes, 6 hours, 8 hours

Log10 reduction in bacteria on the skin evaluated at 10 minutes, 6 hours and 8 hours after treatment. Responder rates (%) are the percentage of sites identified that produced a 2-Log and 3-Log reduction from baseline for abdomen and groin sites respectively.

Percent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites
10 minutes to 8 hours

Percent of abdomen and groin sites that achieve a 2-Log or 3-Log reduction respectively of bacterial flora from baseline. Note: The number of participants in each treatment group (abdomen and/or groin) can vary depending on whether participants achieved qualifying microbial levels on the abdomen and groin at baseline.

Percent Responder Rates (%) of Bacterial Reduction on the Abdomen and Groin
10 minutes, 6 hours, 8 hours

Percent of abdomen and groin sites that showed response (achieve a 2-Log and 3-Log reduction) respectively of bacterial flora from baseline. Note: the number of participants in each treatment group (abdomen and/or groin) can vary depending on whether participants achieved qualifying microbial levels.

Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingSINGLE
ModelPARALLEL
PurposePREVENTION
Treatment Arms
ArmTypeDescription
Chlorhexidine Gluconate ClothEXPERIMENTAL2% CHG, single application
Vehicle ClothPLACEBO_COMPARATORExcipients on cloth
Active Chlorhexidine gluconate solutionACTIVE_COMPARATORDynahex 2% CHG
Interventions
NameTypeDescription
Chlorhexidine gluconateDRUG2% CHG solution on cloth
DynaHex-2DRUG2% CHG solution
VehicleOTHERExcipients of CHG product only
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Males or Females * 18 years of age or older * Signed informed consent * Good Health * Six inches of abdomen and groin areas without tattoos, or skin disorders Exclusion Criteria: * Dermatological Conditions * Sensitivity to latex * Sensitivity to CHG

Countries:RomaniaUnited States
Unlock Eligibility Criteria